Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

Summary

The study is designed as an open labeled pilot trial to analyze the acute responses of glucose, GLP-1, GIP, insulin secretory,and glucagon to a mixed meal tolerance test (MMTT) or intravenous glucose tolerance tests (IVGTT) with and without pretreatment with Exenatide (Byetta) 5 mcg sc. The investigators will also test the effects of Exenatide on gastric emptying during the MMTT.

Timeline

Start

2012-01

Primary completion

2013-07

Completion

2013-10

Drugs

Indications